baber/WOPTO huggingface dataset:
Patent FI-911450-A0 (FI)
Inventor: KORES DIETMAR
IPC: A01N43/58
Filed: 1991-03-26
Abstract: Herbicidal agent containing at least one compound of the formula <IMAGE>  in which   R1 and R2 independently of one another in each case represent the radicals hydroxyl, halogen, cyano, nitro, amino which can optionally be substituted by alkyl having 1 - 4 C atoms, straight-chain or branched alkyl which has 1 - 10 C atoms and which can optionally be monosubstituted or polysubstituted by hydroxyl, halogen or cyano, or are straight-chain or branched alkoxy having 1 - 10 C atoms, cycloalkyl having 5 - 7 C atoms, cycloalkoxy having 5 - 7 C atoms, phenyl, phenoxy, alkylthio or alkylsulphonyl having 1 - 4 C atoms, n and m independently of one another in each case represent the numbers 0, 1, 2 or 3, where n + m represent the numbers 1 to 5, R3 represents the radicals hydroxyl, halogen, -OC(O)ZR4 or -OC(O)NR4R5, where   R4 represents a straight-chain or branched saturated or unsaturated alkyl radical which has 1 - 15 C atoms and which can optionally be substituted by a phenyl radical, or represents a phenyl radical or a cycloalkyl radical having 5 - 7 C atoms, R5 represents a straight-chain or branched saturated or unsaturated alkyl radical which has 1 - 15 C atoms and which can optionally be substituted by a phenyl radical, or represents a phenyl radical or a cycloalkyl radical having 5 - 7 C atoms,   Z is a single bond, oxygen or sulphur and   X is halogen,   or their salts which are tolerated by plants.d
Patent FI-914543-A0 (FI)
Inventor: LAGERQVIST ROGER
IPC: B65F3/00
Filed: 1991-09-26
Abstract: Device for loading and unloading at least two types of waste material through a loading- and unloading opening (7, 8) for each type of material to a container (2) comprising a containment vessel (4, 5) for each type of material. A feeding arrangement (15) feeds waste material from a loading hopper to the containment vessels during a loading phase and seals said opening during a closing phase and the loading hopper is swung away to a withdrawn position during an unloading phase. The feed device (15) extends across the width of both loading- and unloading openings (7, 8) and is common to both openings. The loading hopper consists of a first loading hopper (21) for the first type of waste material and extends across the width of one of the loading- and unloading openings (7) and forms a part of a unit (1) pivotively connected to the container (2), which unit also carries the feed device. A second loading hopper (22) forms a second unit pivotively connected to the container and which extends across the width of the second loading- and unloading opening (8). Unloading the first type of waste material occurs after swinging away solely the first unit with the first loading hopper and feed device. Unloading of the second type of waste material occurs after also swinging away the second unit, whereby both loading hoppers are accordingly swung away.
Patent FI-933402-A0 (FI)
Inventor: SICKEN MARTIN
IPC: C08K5/3492
Filed: 1993-07-29
Abstract: A fire retardant (flame retardant, flame resistant) plastic moulding composition of improved stability comprises   from 50 to 85% by weight, based on the total amount of the moulding composition, of an olefin polymer and from 15 to 50% by weight, based on the total amount of the moulding composition, of a flameproofing system comprising   from 80 to 50% by weight of an ammonium polyphosphate of the formula (NH4PO3)n, in which n is a number from 200 to 1000 (= component A) and from 50 to 20% by weight of a product of the reaction of tris(2-hydroxyethyl) isocyanurate (THEIC) of the formula <IMAGE>  with an aromatic polycarboxylic acid of the formula  Ar(COOH)m  (= component B).   The flameproofing system to be employed according to the invention increases both the processing temperature of the plastic moulding composition and significantly reduces the water solubility of parts of the moulding composition after processing. In addition, the flameproofed plastic parts have a reduced tendency to exude constituents of the flameproofing system.
Patent FI-933501-A0 (FI)
Inventor: KULDVERE JAAKKO ILMARI
IPC: A47B23/00
Filed: 1993-08-09
Abstract: PCT No. PCT/FI94/00336 Sec. 371 Date Jan. 24, 1996 Sec. 102(e) Date Jan. 24, 1996 PCT Filed Aug. 4, 1994 PCT Pub. No. WO95/04483 PCT Pub. Date Feb. 16, 1995The invention is meant to be used on the thigh above the knee. The innovative idea is a concave bottom (FIG. 2 a), which corresponds to the shape of the thigh and a flat surface (FIG. 2 b). Thus, the upper limb can rest on the thigh. In addition, the wrist is more solidly placed in this work position. The upper limb stays better in its position. There is no need to make an unnecessary movement with it or flex it. The upper limb acts as a weight to the ergonomic mouse pad.
Patent FI-934289-A0 (FI)
Inventor: EISENHART ERIC KARL
IPC: C08J5/12
Filed: 1993-09-30
Abstract: An aqueous laminating adhesive composition is disclosed. The composition is adapted to bond difficult-to-adhere substrates. The composition comprises a vinyl ester/acrylic copolymer having a glass transition temperature from about 10  DEG C. to about -45  DEG C. The composition is free from organic cosolvent.
Patent FI-940772-A0 (FI)
Inventor: PEFFLY MARJORIE MOSSMAN
IPC: A61Q5/06
Filed: 1994-02-18
Abstract: The present invention relates to hair spray compositions comprising from about 0.01% to about 2% of an ionic surfactant or a nonionic surfactant having an HLB of about 7 or less; from about 0.5% to about 15% of an ionic resin having a weight average molecular weight of at least about 300,000; and a liquid vehicle. This invention further relates to hairspray compositions comprising from about 0.5% to about 15% of an ionic, silicone macromer-containing resin as the hair setting agent, a liquid vehicle comprising a mixture of water and monohydric alcohol solvent (e.g., C1-C3 monohydric alcohols) wherein the composition contains at least about 10%, by weight of the composition, of water, and an ionic surfactant. Suitable surfactants are organic surfactant selected from the group consisting of anionic surfactants, amphoteric surfactants, zwitterionic surfactants, cationic surfactants, and nonionic surfactants having an average HLB of less than or equal to about 7.
Patent FI-942622-A0 (FI)
Inventor: RUOSLAHTI ERKKI I
IPC: A61K38/00
Filed: 1994-06-03
Abstract: The present invention provides a method for treating or arresting the progress of pathologies characterized by an accumulation of extracellular matrix components by providing an agent to suppress the activity of transforming growth factor  beta  (TGF- beta ) a peptide growth factor which is anabolic and leads to fibrosis and angiogenesis. Pathologies which can be so treated include the various fibrotic diseases such as fibrotic cancer, fibrosis of the lungs, arteriosclerosis, post myocardial infarction, cardiac fibrosis, post-angioplasty restenosis, renal interstitial fibrosis, scarring and diabetic nephropathy. The present invention further provides methods for treating diabetes and pharmaceutical compositions useful in such methods.
Patent FI-945208-A0 (FI)
Inventor: TROFAST EVA ANN-CHRISTIN
IPC: A61M15/00
Filed: 1994-11-04
Abstract: PCT No. PCT/SE93/00389 Sec. 371 Date Nov. 14, 1994 Sec. 102(e) Date Nov. 14, 1994 PCT Filed May 4, 1993 PCT Pub. No. WO93/21980 PCT Pub. Date Nov. 11, 1993A dosage inhalator is provided for dispensing to a patient a pharmacologically active compound suspended in a fluid. The dosage inhalator includes a carrier having portions for carrying, by intermittent movement, predetermined and reproducible unit doses of the active compound to a conduit through which it is delivered; a maneuverer for actuating the intermittent movement of the carrier, the maneuverer being movable between first and second predetermined positions by a user of the inhalator; and a member for disrupting the movement of the maneuverer upon exhaustion of the active compound in the storage means. The carrier is actuated by a ratchet mechanism including a spring-biased pawl, the maneuverer includes a lever that is reciprocally displaceable between two distinct positions, and the movement of the ratchet mechanism is limited by the displacement of the lever.
Patent FI-954165-A0 (FI)
Inventor: VAN COILLIE ANDRE SYLVERE JOSE
IPC: F04D7/02
Filed: 1995-09-06
Abstract: The invention relates to a pumping device for relatively volatile liquid, comprising a closed pump housing having an intake connected to a supply reservoir and at least one discharge connected to a delivery means. The device further comprises a liquid pump with a liquid inlet drawing into the interior of the pump housing and a pressure outlet connected to the discharge, a gas pump with a gas inlet drawing into the pump housing at a high level and a gas outlet debouching outside the pump housing and wherein the liquid pump is a hydrodynamic pump such as a centrifugal pump. <MATH>
Patent FI-961537-A0 (FI)
Inventor: ZIMMERMANN THOMAS
IPC: C12R1/01
Filed: 1996-04-04
Abstract: PCT No. PCT/EP94/03317 Sec. 371 Date Jul. 2, 1996 Sec. 102(e) Date Jul. 2, 1996 PCT Filed Oct. 7, 1994 PCT Pub. No. WO95/10613 PCT Pub. Date Apr. 20, 1995An isolated DNA fragment including the genes bcoC, bcoA/B, bcoD coding for the enzymes for L-carnitine biosynthesis in  gamma -butyrobetaine/crotonobetaine metabolism and, additionally, including the gene bcoT coding for a potential transport protein in  gamma -butyrobetaine/crotonobetaine metabolism. Also, any vector which includes an isolated DNA fragment including the genes bcoC, bcoA/B, bcoD coding for the enzymes for L-carnitine biosynthesis in  gamma -butyrobetaine/crotonobetaine metabolism and, additionally, including the gene bcoT coding for a potential transport protein in  gamma -butyrobetaine/crotonobetaine metabolism. Also, biotechnological process for the production of L-carnitine characterized in that crotonobetaine and/or  gamma -butyrobetaine is fermented in the presence of a suitable carbon and nitrogen source using a microorgansim and L-carnitine is isolated.
Patent FI-972974-A0 (FI)
Inventor: TUUNANEN HEIKKI
IPC: H04M3/36
Filed: 1997-07-11
Abstract: A method of reducing message traffic between a service control point and a switching point for executing an intelligent network service in the service switching point. A service logic comprising the operations the execution of which implements said intelligent network service is formed for each intelligent network service to be executed in the switching point. The service switching point receives the service logic, and at lest one criterion, upon the fulfillment of which the service switching point is to execute said operations. Upon fulfillment of said criterion, the service switching point executes said operations.
Patent IL-72166-A0 (IL)
Title: Beta-carboline derivatives and pharmaceutical compositions containing the same
IPC: A61K31/437
Filed: 1984-06-20
Abstract: beta -carboline derivatives of general Formula I    <IMAGE>  (I) wherein R3 is   <IMAGE>  wherein R5 is C1-5 alkyl, R6 is lower alkyl, aralkyl, or alkoxyalkyl of up to 7 carbon atoms, and R7 and R8 are hydrogen C1-5 alkyl, or, collectively with the amido nitrogen atom, piperidino, R4 is hydrogen, C1-3 alkyl, or CH2OR9 wherein R9 is C1-3 alkyl, atoms, and RA is -COOR10    <IMAGE>   wherein R10 is hydrogen, lower alkyl, alkoxyalkyl or alkenyl of up to 5 carbon atoms, or benzyl, or X is oxygen or sulfur, and R11 and R12 each are hydrogen, lower alkyl or alkenyl or, collectively with the amido nitrogen atom, represent a hetero ring, are prepared by conventional methods and exhibit, inter alia, an effect on the central nervous system and are suitable for use as psychopharmaceuticals.
Patent IL-75608-A0 (IL)
Title: Substituted 5-acylamino-1-phenylpyrazoles,their preparation and their use as herbicides
IPC: A01N47/22
Filed: 1985-06-24
Abstract: 5-acylamino-1-phenylpyrazole herbicides of the formula   <IMAGE>   in which R represents cyano, alkoxycarbonyl, alkenyloxycarbonyl, alkinyloxycarbonyl, aminocarbonyl, alkylaminocarbonyl, alkenylaminocarbonyl or alkinylaminocarbonyl, R1 represents alkyl, alkenyl, alkinyl, alkoxyalkyl, alkylthioalkyl, halogenoalkyl, cycloalkyl or optionally substituted aryl, and, in the case in which Y represents the   <IMAGE>   group, also represents hydrogen, X represents oxygen or sulphur, Y represents oxygen, sulphur or the <IMAGE>   group, wherein Z represents hydrogen, alkyl, alkoxy, alkenyl, alkinyl or optionally substituted aryl, R2 represents hydrogen or the radical   <IMAGE>   and R3, R4, R5, R6 and R7, which are identical or different, represent hydrogen, halogen, cyano, nitro, alkyl, alkoxy, alkylsulphonyl, alkoxycarbonyl or a radical -(X')n-R8, wherein X' represents oxygen, sulphur, sulphinyl or sulphonyl, n represents 0 or 1 and R8 represents halogenoalkyl, with the proviso that at least one of the radicals R3, R4, R5, R6 or R7 represents a radical -(X')n-R8, but R does not represent cyano when R5 represents trifluoromethyl.
Patent IL-81509-A0 (IL)
Title: Improved label for use in antitheft surveillance system
IPC: C23C14/34
Filed: 1987-02-09
Abstract: A label for use in a high frequency anti-theft surveillance system. Permanently magnetized members (24, 26) are disposed adjacent a ferromagnetic nonlinear element (30) for biasing the hysteresis loop of the nonlinear element (30) near the knee (40) of the magnetization curve. The nonlinear element (30) includes low permeability sections (32, 34) and high permeability section (36). The high permeability section (36) of the nonlinear element (30) is disposed adjacent a radiating dipole (28) for radiating the summation frequency of a pair of frequencies impinging on the nonlinear element (30). A memory magnet (38) with a changeable magnetism is disposed adjacent the high reluctance section (36) of the nonlinear element (30). The magnetism of the memory magnet (38) can be changed to provide either an active or inactive status of the label (16).
Patent IL-93156-A0 (IL)
Title: Novel monoclonal antibody to novel antigen associated with human tumors
IPC: A61K49/00
Filed: 1990-01-23
Abstract: The present invention is concerned with a novel monoclonal antibody which binds strongly to a protein antigen associated with human tumors, including carcinomas of the colon, breast, ovary and lung, as well as melanomas and sarcomas. The antibody binds to normal human cells to a much lesser degree than to tumor cells. The antibody finds use both in diagnostic methods such as the detection of malignant cells associated with tumors and in therapeutic methods for treatment of humans with tumors. Also disclosed is a novel 100,000 dalton glycoprotein antigen found on the cell surface of human tumor cells. The amino terminal amino acid sequence of this antigen is:  <IMAGE> +TR  <IMAGE>  in which X represents an unidentified amino acid.
Patent IL-93468-A0 (IL)
Title: Pay-television system
IPC: H04N7/167
Filed: 1990-02-20
Abstract: PCT No. PCT/CH90/00040 Sec. 371 Date Oct. 19, 1990 Sec. 102(e) Date Oct. 19, 1990 PCT Filed Feb. 21, 1990 PCT Pub. No. WO90/10354 PCT Pub. Date Sep. 7, 1990.According to the invention, on the emitter side, a number generator (10) delivers a random code (XAL) which is sent to the input of a master card (11) which ciphers such code according to a predetermined key (100), the code thus ciphered is broadcast with the video signal, a first device (17) receives, on the one hand, the random code (XA) and, on the other hand, the code ciphered by the master card (11) and effects a predetermined numerical combination of these two codes, such combination forming the initialization word of a pseudo-random generator (12) intended to provide a table of codes for scrambling the video signal and, on the receiver side, the ciphered code received is deciphered by a customer card (13), a second device (18) receives at the inputs, on the one hand, the ciphered code and, on the other hand, the code deciphered (XA) by the customer card (13) and effects a numerical combination of these two codes which is similar to the combination of the first device (17).
Patent IL-100833-A0 (IL)
Title: Method for synthesis of ethereally substituted blocked monosaccharides
IPC: C07H15/04
Filed: 1992-01-31
Abstract: A solvent-free method for synthesizing an ethereally-substituted, blocked monosaccharide comprising the steps of:   1) mixing, in the absence of solvent, a partially blocked monosaccharide unblocked at one position, an alkyl halide or a substituted alkyl halide, and an anhydrous alkali base; 2) heating the mixture to a temperature sufficient to allow the mixture to react; 3) maintaining the mixture at a suitable temperature for a time sufficient to form an ethereally-substituted blocked monosaccharide and drive off any water produced; 4) removing any unreacted alkyl halide or substituted alkyl halide from the mixture; 5) recovering the ethereally-substituted blocked monosaccharide product from the mixture; and, optionally, 6) selectively hydrolyzing the ethereally-substituted blocked monosaccharide product to remove one or more of the acetal blocking groups. e
Patent IL-104105-A0 (IL)
Title: New 19-nor steroids having a thiocarbon chain in position 11-beta,their preparation process and pharmaceutical compositions containing them
Inventor: CLAUSSNER ANDRE
IPC: A61K31/565
Filed: 1992-12-15
Abstract: Compounds of formula (I), wherein R17 and R'17 are such that: either R17 and R'17 together form ketone, hydrazono, oxime or methylene, or R17 is hydroxyl, hydroxymethyl or acyloxy and R'17 is hydrogen, alkyl or optionally substitued alkenyl or alkynyl; R3 is hydrogen or alkyl; R16 is hydrogen, halogen or alkyl; m is 0, 1 or 2; X, Y and Z are such that: X is methylene, arylene or arylenoxy bonded to the steroid by a carbon atom; Y is a saturated or unsaturated straight or branched aliphatic chain which is optionally interrupted by oxygen; and Z is aryl, arylalkyl or straight or branched alkyl; addition salts thereof, a preparation method therefor, medicinal uses thereof, compositions containing said compounds, and resulting novel intermediates.
Patent IL-130190-A0 (IL)
Title: Methods and compositions for polypeptide engineering
IPC: C12P21/02
Filed: 1997-12-17
Abstract: Methods are provided for the evolution of proteins of industrial and pharmaceutical interest, including methods for effecting combination and selection. Compositions produced by these methods are also disclosed.
Patent IL-136088-A0 (IL)
Title: 6-0-alkyl erythromycin b oxime
IPC: A61K31/7042
Filed: 1998-11-17
Abstract: A process of preparing a 6-O-alkyl derivative of 9-oxime erythromycin B is provided. Intermediates used in the preparation of a 6-O-alkyl 9-oxime erythromycin B are also provided. Pharmaceutical compositions containing a 6-O-alkyl derivative of 9-oxime erythromycin B and the use of those compositions to treat bacterial infections are also provided.
Patent IL-139426-A0 (IL)
Title: Transducer interface arrangement including a sigma-delta modulator with offset correction and with gain setting
IPC: H03M1/12
Filed: 2000-11-02
Abstract: A transducer interface arrangement including sensor means (SM) for measuring a parameter such as temperature, pressure, ..., an Analog-to-Digital Converter (ADCb) including a Sigma-Delta Modulator (SDMb), and a selectable resistor string (SRSa). The data input of the Sigma-Delta Modulator is connected to the series combination of a first switched-capacitor module (SC1, SC1b), a first differential amplifier (A1), a second switched-capacitor module (SC2) and a second differential amplifier (A2), followed by a comparator (CP). The modulator further comprises a third (SC3) and a fourth (SC4) switched-capacitor module to which a reference voltage is applied and which are respectively connected to the input of the first and the second amplifier. To reduce the chip area and power consumption while increasing the performance of the arrangement, an offset canceling pre-amplifier to the A/D converter is advantageously replaced by a fifth switched-capacitor module (SC5), to which an offset voltage is applied. The offset voltage is provided, together with the reference voltage, by the selectable resistor string (SRSa). In addition to the improved offset correction, the present transducer interface arrangement is also provided with simple gain setting means. To this end, gain setting modules consisting of one or more switchable capacitive branches coupled in parallel with existing capacitors in the first switched-capacitor module (SC1b). The more branches which are added, the higher the gain. <IMAGE>   <IMAGE>
Patent IL-150800-A0 (IL)
Title: The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
IPC: A61P27/06
Filed: 2001-01-22
Abstract: Methods are provided for treating injury to or disease of the central or peripheral nervous system. In one embodiment, treatment is effected by administering activated T cells that recognize an antigen of Cop 1 or a Cop 1-related peptide or polypeptide to promote nerve regeneration or to prevent or inhibit neuronal degeneration within the nervous system. In another embodiment, treatment involves administering Cop 1 or a Cop 1-related peptide or polypeptide to promote nerve regeneration or to prevent or inhibit neuronal degeneration in the nervous system, either the central nervous system or the peripheral nervous system. The activated T cells, which have been activated by the presence of Cop 1 or a Cop 1-related peptide or polypeptide, can be administered alone or in combination with Cop 1 or a Cop 1-related peptide or polypeptide.
Patent IL-151860-A0 (IL)
Title: Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same
IPC: C07K14/47
Filed: 2001-03-19
Abstract: A nucleic acid construct encoding a single chain MHC class I polypeptide comprises (a) a first nucleic acid sequence comprising a first polynucleotide encoding a functional mammalian ²-2 microglobulin being translationally fused upstream of a second polynucleotide encoding a functional mammalian MHC class I heavy chain; and (b) a cis acting regulatory sequence being selected capable for directing expression of said first nucleic acid sequence in bacteria.
Patent AP-2000001949-A0 (AP)
Title: 4-Benzyl piperidine alkysulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists.
Inventor: WRIGHT JONATHAN L
IPC: A61P25/18
Filed: 1999-06-25
Abstract: Novel 4-benzyl piperidine alkylsulfoxide heterocycles are disclosed and their use as subtype selective nmda receptor antagonists, particularly for the treatment of parkinson's disease, most preferably in combination with l-dopa.
Patent IT-9000642-A1 (IT)
Inventor: MUZZARELLI RICCARDO
IPC: A61K9/00
Filed: 1990-11-26
Abstract: PCT No. PCT/EP91/02168 Sec. 371 Date Jul. 27, 1992 Sec. 102(e) Date Jul. 27, 1992 PCT Filed Nov. 18, 1991 PCT Pub. No. WO92/09635 PCT Pub. Date Jun. 11, 1992.Modified chitins and chitosans with recurring units of the formula   <IMAGE>   wherein R denotes -NH2, -NHCOCH3 and R', with R' being present in at least 30% of the recurring units, characterized in that R' represents a group of the formula   their favourable biological properties, these materials are advantageously useful in medical and cosmetical applications.
Patent LU-85591-A1 (LU)
Inventor: STEINHAGEN ROLF HEINRICH
IPC: B08B9/02
Filed: 1984-10-12
Abstract: An equipment assembly for mixing a disinfectant soln. and then using the soln. to clean vessels, pipes, flexible tubes, endoscopes etc.  A water supply is connected to a dosing unit which has a branch inlet for disinfectant from a reservoir.  The dosing unit delivers cleaning liq. contg. disinfectant, pref. via a pressure reducing valve to the items to be cleaned.  The assembly is pref. constructed as a packaged unit.